New biosimilar drug studied for advanced colorectal cancer
Disease control
Recruiting now
This study looks at how well a biosimilar version of bevacizumab (called Elovie) works and how safe it is for people with advanced colorectal cancer that has spread and cannot be removed by surgery. About 133 adults will be followed as they receive this drug as their first treatm…
Sponsor: Libbs Farmacêutica LTDA • Aim: Disease control
Last updated May 17, 2026 04:10 UTC